Screening of 368 consecutive nonreplicate clinical isolates of Enterobacteriaceae resistant to nalidixic acid and at least one extended-spectrum ␤-lactam revealed the presence of qnrA, qnrB, and qnrS determinants, and identified novel qnrB variants, in Citrobacter freundii isolates. This study also revealed, for the first time, the linkage of qnrB, armA, and extended-spectrum and/or AmpC-type ␤-lactamase genes on large conjugative plasmids.
Since the first plasmid-mediated quinolone resistance (PMQR) was reported in 1998 for a Klebsiella pneumoniae isolate from the United States (10), three PMQR mechanisms have been discovered. The first PMQR mechanism involves qnr genes that have been reported worldwide in various enterobacterial species (2, 4, 5, 7, 9, 10, 13, 18, 23, 24) . The second consists of the AAC(6Ј)-Ib-cr gene, which encodes a new variant of the common aminoglycoside acetyltransferase that is capable of acetylating the piperazinyl substituent of some fluoroquinolones (20) and thereby reducing their activities. A novel plasmidmediated fluoroquinolone efflux pump protein, QepA, has recently been reported simultaneously from Japan (26) and Europe (16) as the third PMQR mechanism. A strong association of quinolone resistance with the production of extendedspectrum ␤-lactamases (ESBLs) or plasmid-mediated AmpC ␤-lactamases (pACBLs) has been observed (7, 9, 13, 18, 24) . The association between qnrA and ESBL determinants for SHV-5 (12, 24) , , CTX-M-9 (23), CTX-M-14 (2), CTX-M-15 (7) , and VEB-1 (17) or pACBL determinants for DHA-1 (13, 24) and FOX-5 (10) has been reported repeatedly. Similarly, qnrB has been reported to be located on plasmids carrying bla genes for CTX-M-15, SHV-12 (7), or SHV-30 (4) ESBLs. In Korea, recent studies have shown a strong association between qnrB4 and bla DHA-1 in members of the Enterobacteriaceae (14, 15) .
In this study, the prevalences of the three major families of qnr determinants, and the association of qnr genes with ESBL, pACBL, and/or plasmid-mediated 16S rRNA methylase genes, among 368 nonduplicate clinical isolates of Enterobacteriaceae resistant to nalidixic acid and at least one of the extendedspectrum ␤-lactams (cefoxitin, cefotaxime, cefepime, aztreonam, or ceftazidime), consecutively collected during 2004 to 2006 at Kyungpook National University Hospital in the Republic of Korea, were investigated.
The qnrA, qnrB, and qnrS genes were detected by multiplex PCR as described previously (19) . A total of 141 (38.3%) isolates were qnr positive. Each of the three qnr families was detected, but none of the isolates harbored two or more types of qnr genes simultaneously. The qnrA, qnrB, and qnrS genes were detected in 4 (1.0%), 135 (36.7%), and 2 (0.5%) of the total isolates, respectively. The qnrB determinants were most commonly detected in Citrobacter freundii isolates (67.9%), followed by K. pneumoniae (62.5%), Enterobacter cloacae (15.8%), and Escherichia coli (9.4%) isolates. While qnrA was detected only in E. cloacae isolates, qnrS was detected in one K. pneumoniae and one E. coli isolate ( Table 1 ). The high prevalence of qnrB in this study is in good agreement with the findings of previous studies conducted in Korea (14) and Taiwan (25) .
All qnrA and qnrS amplicons were confirmed by sequencing. The sequences of the four qnrA amplicons were identical to that of qnrA1 from K. pneumoniae plasmid pMG252 (10) , and those of the two qnrS amplicons were identical to that of qnrS1 from Shigella flexneri 2b plasmid pAH0376 from Japan (5). A restriction fragment length polymorphism (RFLP) protocol was developed in conjunction with the multiplex PCR, as outlined in Fig. 1 , to differentiate between qnrB variants. RFLP analysis of the PCR products obtained from 135 qnrB-positive isolates revealed several variants, including 15 (4%) qnrB1, 1 (0.2%) qnrB2, 113 (30.7%) qnrB4, and 2 (0.5%) qnrB6 amplicons, and four original RFLP profiles that did not match with variants detectable by this typing protocol. Sequencing of the qnrB2 and qnrB6 amplicons and of representatives of the qnrB1 (n ϭ 5) and qnrB4 (n ϭ 10) amplicons confirmed their identities. In order to determine the sequences of the qnrB genes yielding unique RFLP profiles, primers QnrB-1-10-F (ATGA CGCCATTACTGTATAAAAAA) and QnrB-1-10-R (CTAG CCAATAATCGCGATGCCA) were used to obtain a 681-bp PCR product. In addition to direct sequencing of amplicons obtained with the original genomic DNA, the corresponding amplicons were cloned into a pGEM-T vector (Promega, Madison, WI) and sequenced, and their sequences were confirmed and compared with known sequences by using the BLAST programs at the National Center for Biotechnology Information (http://www.ncbi.nlm.nih.gov/BLAST). Three novel qnrB variants, which exhibited 97 to 98% nucleotide sequence identity and Ͼ98% amino acid identity with each other, were identified among the C. freundii strains (Fig. 2) . As proposed in the recently published Commentary on Qnr numbering by Jacoby et al. (6) , they are designated qnrB13, qnrB14, and qnrB15, respectively, and each of them codes for a 214-amino-acid protein. qnrB13 exhibits the highest degrees of nucleotide (98.9%) and amino acid (99.5%) sequence identity to qnrB2 (GenBank accession no. DQ351242), whereas qnrB14 and qnrB15 exhibit the highest degrees of nucleotide (97.7%) and amino acid (99.1%) sequence identity to qnrB9 (GenBank accession no. EF526508).
A multiplex PCR to identify bla SHV , bla CTX-M-1 -like, and bla CTX-M-9 -like genes and simplex PCRs to identify the bla DHA-1 gene and 16S rRNA methylase genes (rmtA, rmtB, and armA) were carried out with clinical isolates and their transconjugants as described previously (3, 8, 27) . The distribution of these other resistance determinants among the qnrpositive clinical isolates of Enterobacteriaceae is shown in Table  1 . Of the 141 qnr-positive isolates, ESBL and/or pACBL genes were detected in 122 (86.5%). However, no ESBL and/or pACBL gene was detected among the 19 C. freundii isolates carrying qnrB variants. Upon further investigation, it was found that three of these isolates produced a ␤-lactamase with a pI of 5.4, consistent with bla TEM-1 , a finding that was also corrobo- 
a The TEM-derived ␤-lactamase is not described in this Transconjugants were selected on Mueller-Hinton agar (Difco) plates supplemented with ampicillin (32 g/ml) and sodium azide (200 g/ml) or rifampin (50 g/ml). Conjugal transfer for ampicillin resistance was successful for 70 donor isolates. However, only 32% (43 qnrB4, 2 qnrB6, and 1 qnrS isolate) of the total donor isolates transferred qnr determinants. The apparent lack of transfer of qnr determinants for the remaining 68% of the isolates could be due to their presence on nonconjugative plasmids. Alternatively, it could be due to their chromosomal location, as a result of integration of the qnr-carrying plasmid back into the chromosome. Further study should be done to prove this hypothesis. MICs were determined by the agar dilution method (11) . The MICs of nalidixic acid and ciprofloxacin for the qnr-positive transconjugants were as much as severalfold higher than those for the recipients ( Table 2 ). The transconjugants carrying qnrB6 and qnrS1 exhibited the highest increases in MICs. Overall, 35 transconjugants simultaneously carried qnrB4, bla DHA-1 , bla , and armA with or without other ESBL genes ( Table 2) . PCR-based inc replicon typing, performed for the 46 qnr-positive transconjugants using boiled DNA templates, as described previously (1), identified FIIAs, FIA, and L/M plasmids in 32, 3, and 1 transconjugant, respectively, all of which were qnrB4 positive, except for 2 that were positive for qnrB6 and qnrS1, respectively ( Table 2) .
Isolation of plasmid DNA from nine randomly selected transconjugants positive for qnrB4 (of which six also carried the bla DHA-1 , bla , and armA genes, and three carried different combinations of two of these genes) by the alkaline lysis method (21) revealed a large plasmid of approximately 180 kb. Southern hybridization using probes specific for the qnrB4, bla DHA-1 , bla , and armA genes revealed that all determinants were apparently carried on the same plasmid (Fig. 3) . The plasmids derived from the transconjugants were similar in size, belonged to the FIIAs inc type, and carried the qnrB4, bla DHA-1 , bla , and armA genes. Furthermore, Southern hybridization of the plasmid DNAs isolated from the two transconjugants positive for qnrB6, bla DHA-1 , and armA determinants revealed that the determinants were apparently carried on the same large plasmid (data not shown). However, another, relatively smaller, nonconjugative plasmid was also hybridized with a probe specific for qnrB6 in addition to the large conjugative plasmid, indicating the presence of qnrB6 on two plasmids of different sizes in the same clinical strain but not in the corresponding transconjugants (data not shown). Thus, the spread of multidrug-resistant Enterobacteriaceae simultaneously carrying the qnrB, bla DHA-1 , bla , and armA genes was due mainly to dissemination of a large inc FIIAs conjugative plasmid. Although the spread of multidrug-resistant E. coli and K. pneumoniae isolates that produce both ESBLs and 16S rRNA methylases has been reported (27) , and   FIG. 2 . CLUSTAL W alignment of deduced amino acid sequences of the novel qnrB variants described in this study: QnrB13 (GenBank accession no. ABX72042), QnrB14 (ABX72044), and QnrB15 (ABX72227). Asterisks represent amino acid residues identical to those in the QnrB13 sequence. several reports have also demonstrated the association between qnr determinants and the ESBL and/or pACBL genes (7, 9, 13, 18, 24) , the association between qnr determinants, ESBL and/or pACBL genes, and 16S rRNA methylase genes on the same conjugative plasmid had never been reported before.
In conclusion, this is the first report of the simultaneous association of qnrB, armA, and ESBL and/or AmpC ␤-lactamase genes on large conjugative plasmids found in clinical isolates, which consequently were resistant to almost all clinically important antimicrobial agents.
Nucleotide sequence accession numbers. The nucleotide sequences of the novel qnrB variants in C. freundii strains 05K657, 05K1560, 06K619, and 06K1424, determined in this study, have been submitted to GenBank and have been assigned accession no. EU273755, EU273756, EU273757, and EU302865, respectively. 
